Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer

被引：0
|
作者：
Brian M Nolen
Jeffrey R Marks
Shlomo Ta'san
Alex Rand
The Minh Luong
Yun Wang
Kimberly Blackwell
Anna E Lokshin
机构：
[1] University of Pittsburgh Cancer Institute,Department of Surgery
[2] Hillman Cancer Center,Department of Mathematical Sciences
[3] Duke University Medical Center,Department of Biostatistics, Graduate School of Public Health
[4] Carnegie Mellon University,Department of Radiation Oncology
[5] University of Pittsburgh,Department of Medicine
[6] Duke University Medical Center,Department of Medicine, School of Medicine
[7] Duke University Medical Center,Department of Pathology
[8] University of Pittsburgh,Department of Obstetrics and Gynecology RS
[9] University of Pittsburgh,undefined
[10] University of Pittsburgh,undefined
来源：
Breast Cancer Research | / 10卷
关键词：
Epidermal Growth Factor Receptor; Migration Inhibitory Factor; Median Fluorescence Intensity; Locally Advanced Breast Cancer; Clinical Partial Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy for Chinese women with locally advanced breast cancer
    Chow, LWC
    Day, WD
    Ng, KCK
    [J]. AMERICAN SURGEON, 2001, 67 (05) : 412 - 416
  • [42] Neoadjuvant chemotherapy in locally advanced breast cancer:: a preliminary report
    Baltali, E
    Günel, N
    Onat, DA
    Atahan, IL
    Akcali, Z
    Büyükünal, E
    Aktan, G
    Firat, D
    [J]. 2ND BALKAN CONGRESS OF ONCOLOGY, 1999, : 185 - 195
  • [43] Outcomes of neoadjuvant Chemotherapy (CHT) in locally advanced Breast cancer
    Schulz-Ertner, D.
    Kaufmann, O.
    Garcia-Huttenlocher, H.
    Khandan, F.
    Herrmann, W.
    Brandi, C.
    Gauwerky, J.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 64 - 65
  • [44] Neoadjuvant chemotherapy, locally advanced breast cancer, and quality of life
    McMasters, KM
    Hunt, KK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 441 - 444
  • [45] Melatonin and metformin in neoadjuvant chemotherapy in locally advanced breast cancer
    Semiglazova, T. Y.
    Osipov, M.
    Krivorotko, P.
    Semiglazov, V.
    Protsenko, S.
    Berstein, L.
    Tsirlina, E.
    Klimenko, V.
    Donskih, R.
    Anisimov, V.
    Belyaev, A.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [46] Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer
    Moll, UM
    Chumas, J
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1997, 193 (03) : 187 - 196
  • [47] Use of neoadjuvant chemotherapy in locally advanced breast cancer in the Netherlands
    Spronk, P. E. R.
    Van Bommel, A. C. M.
    Siesling, S.
    Peeters, M. J. T. Baas-Vrancken
    Smorenburg, C. H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S93 - S93
  • [48] Combined Neoadjuvant Chemotherapy and Celecoxib in Locally Advanced Breast Cancer
    Ahmadloo, N.
    Mozaffari, M. A. Nazer
    Mohammadianpanah, M.
    Omidvari, S. H.
    Mosalaei, A.
    Shirazi, M. A. Mosleh
    [J]. IRANIAN RED CRESCENT MEDICAL JOURNAL, 2009, 11 (04) : 419 - 424
  • [49] Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?
    Bozkaya, Yakup
    Ozdemir, Nuriye Yildirim
    Sezer, Sevilay
    Kostek, Osman
    Demirci, Nebi Serkan
    Yazici, Ozan
    Erdem, Gokmen Umut
    Eren, Tulay
    Zengin, Nurullah
    [J]. CANCER BIOMARKERS, 2018, 22 (01) : 143 - 149
  • [50] Role of breast imaging with histopathological correlation in evaluating the response of locally advanced breast cancer to neoadjuvant chemotherapy
    Syed, Anjum
    Premi, Vimugdha
    Varghese, Reshma
    Arora, Manali
    Kapoor, Aakriti
    Kattupalli, Satish
    Sharda, Prateek
    Gupta, Manoj
    Ravi, Bina
    [J]. BREAST JOURNAL, 2020, 26 (11): : 2272 - 2275
12345